Literature DB >> 16023414

Amelioration of both functional and morphological abnormalities in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer.

Enrico Maria Surace1, Luciano Domenici, Katia Cortese, Gabriella Cotugno, Umberto Di Vicino, Consuelo Venturi, Alessandro Cellerino, Valeria Marigo, Carlo Tacchetti, Andrea Ballabio, Alberto Auricchio.   

Abstract

X-linked recessive ocular albinism type I (OA1) is due to mutations in the OA1 gene (approved gene symbol GPR143), which is expressed in the retinal pigment epithelium (RPE). The Oa1 (Gpr143) knockout mouse (Oa1(-/-)) model recapitulates many of the OA1 retinal morphological anomalies, including a lower number of melanosomes of increased size in the RPE. The Oa1(-/-) mouse also displays some of the retinal developmental abnormalities observed in albino patients such as misrouting of the optic tracts. Here, we show that these anomalies are associated with retinal electrophysiological abnormalities, including significant decrease in a- and b-wave amplitude and delayed recovery of b-wave amplitude from photoreceptor desensitization following bright light exposure. This suggests that lack of Oa1 in the RPE impacts on photoreceptor activity. More interestingly, adeno-associated viral vector-mediated Oa1 gene transfer to the retina of the Oa1(-/-) mouse model results in significant recovery of its retinal functional abnormalities. In addition, Oa1 retinal gene transfer increases the number of melanosomes in the Oa1(-/-) mouse RPE. Our data show that gene transfer to the adult retina unexpectedly rescues both functional and morphological abnormalities in a retinal developmental disorder, opening novel potential therapeutic perspectives for this and other forms of albinism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023414     DOI: 10.1016/j.ymthe.2005.06.001

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  14 in total

1.  Gene delivery to the retina: from mouse to man.

Authors:  Jean Bennett; Daniel C Chung; Albert Maguire
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 2.  Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.

Authors:  Pasqualina Colella; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2012-08       Impact factor: 5.695

3.  Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Authors:  Annagiusi Gargiulo; Francesco Testa; Settimio Rossi; Valentina Di Iorio; Simona Fecarotta; Teresa de Berardinis; Antonello Iovine; Adriano Magli; Sabrina Signorini; Elisa Fazzi; Maria Silvana Galantuomo; Maurizio Fossarello; Sandro Montefusco; Alfredo Ciccodicola; Alberto Neri; Claudio Macaluso; Francesca Simonelli; Enrico Maria Surace
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

4.  Gene delivery in the equine cornea: a novel therapeutic strategy.

Authors:  Dylan G Buss; Elizabeth Giuliano; Ajay Sharma; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2010-09       Impact factor: 1.644

5.  A novel iris transillumination grading scale allowing flexible assessment with quantitative image analysis and visual matching.

Authors:  Chen Wang; Flavia Brancusi; Zaheer M Valivullah; Michael G Anderson; Denise Cunningham; Adam Hedberg-Buenz; Bradley Power; Dimitre Simeonov; William A Gahl; Wadih M Zein; David R Adams; Brian Brooks
Journal:  Ophthalmic Genet       Date:  2017-07-25       Impact factor: 1.803

6.  AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1).

Authors:  Annagiusi Gargiulo; Ciro Bonetti; Sandro Montefusco; Simona Neglia; Umberto Di Vicino; Elena Marrocco; Michele Della Corte; Luciano Domenici; Alberto Auricchio; Enrico M Surace
Journal:  Mol Ther       Date:  2009-05-12       Impact factor: 11.454

7.  Involvement of OA1, an intracellular GPCR, and G alpha i3, its binding protein, in melanosomal biogenesis and optic pathway formation.

Authors:  Alejandra Young; Elisabeth B Powelson; Irene E Whitney; Mary A Raven; Steven Nusinowitz; Meisheng Jiang; Lutz Birnbaumer; Benjamin E Reese; Debora B Farber
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

8.  Myosin7a deficiency results in reduced retinal activity which is improved by gene therapy.

Authors:  Pasqualina Colella; Andrea Sommella; Elena Marrocco; Umberto Di Vicino; Elena Polishchuk; Marina Garcia Garrido; Mathias W Seeliger; Roman Polishchuk; Alberto Auricchio
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

9.  Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors.

Authors:  Mariacarmela Allocca; Claudio Mussolino; Maria Garcia-Hoyos; Daniela Sanges; Carolina Iodice; Marco Petrillo; Luk H Vandenberghe; James M Wilson; Valeria Marigo; Enrico M Surace; Alberto Auricchio
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

10.  Conjunctivally Applied BDNF Protects Photoreceptors from Light-Induced Damage.

Authors:  Elisa Cerri; Nicola Origlia; Benedetto Falsini; Davide Barloscio; Carlotta Fabiani; Marco Sansò; Sara Ottino; Luca Giovannini; Luciano Domenici
Journal:  Transl Vis Sci Technol       Date:  2015-11-02       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.